Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort study
14
Zitationen
28
Autoren
2023
Jahr
Abstract
Für dieses Paper ist kein Abstract in der Datenbank hinterlegt.
Abstract beim Verlag einsehenÄhnliche Arbeiten
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 · 5.693 Zit.
Decision Curve Analysis: A Novel Method for Evaluating Prediction Models
2006 · 5.090 Zit.
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 · 4.535 Zit.
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
1998 · 4.488 Zit.
Screening and Prostate-Cancer Mortality in a Randomized European Study
2009 · 3.990 Zit.
Autoren
- Jethro C.C. Kwong
- Adree Khondker
- Eric Meng
- Nicholas Taylor
- Cynthia Kuk
- Nathan Perlis
- Girish S. Kulkarni
- Robert J. Hamilton
- Neil Fleshner
- Antonio Finelli
- Theodorus van der Kwast
- Amna Ali
- Munir Jamal
- Frank Papanikolaou
- Thomas Short
- John R. Srigley
- Valentin Colinet
- Alexandre Peltier
- Romain Diamand
- Yolène Lefebvre
- Qusay Mandoorah
- Rafael Sanchez‐Salas
- Petr Macek
- Xavier Cathelineau
- Martin Eklund
- Alistair E. W. Johnson
- Andrew Feifer
- Alexandre R. Zlotta
Institutionen
- University Health Network(CA)
- Princess Margaret Cancer Centre(CA)
- University of Toronto(CA)
- Queen's University(CA)
- Sinai Health System(CA)
- Mount Sinai Hospital(CA)
- Trillium Health Centre(CA)
- Institut Jules Bordet(BE)
- Institute Mutualiste Montsouris(FR)
- Karolinska Institutet(SE)
- Public Health Ontario(CA)
- Vector Institute(CA)